UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Innovative Covid-19 diagnostics and testing strategies in Italy, Denmark, UK, Israel and Sweden: a comparative analysis including tests, incidence and mortality

Melodia, P; Stocchi, M; Gentile, L; Odone, A; Renzi, C; Signorelli, C; (2023) Innovative Covid-19 diagnostics and testing strategies in Italy, Denmark, UK, Israel and Sweden: a comparative analysis including tests, incidence and mortality. Acta Biomedica , 94 (S3) , Article e2023190. 10.23750/abm.v94iS3.14565. Green open access

[thumbnail of Renzi_18-abm-14565.pdf]
Preview
Text
Renzi_18-abm-14565.pdf

Download (761kB) | Preview

Abstract

Background and aim: Detecting SARS-CoV-2 remains a critical component in the global effort to control COVID-19, particularly with the emergence of variants. Since the outbreak, diagnostic techniques have evolved to meet different contexts and needs. Methods: In this study, we analyzed the use of these techniques in five countries (i.e. Italy, Denmark, the United Kingdom, Sweden, and Israel) based on their specific national testing and contact tracing strategies. We also examined the number of tests performed per week, the positivity rate of tests, and the mortality rate in these populations during the same time periods. These countries were chosen based on the directives of the consortium involved in the CORONADX project. Results: During the three-year period under review, Italy and Denmark adopted large-scale testing strategies over a long period of time, with different results: in Italy an average of 4.5% of the population adhered to diagnosis, in Denmark 21%, while Israel reached 6.5%. The UK prioritised mass testing for short periods, outperforming the other countries with 1,882,596,198 total swabs and an average adherence of 28.1% of the population. Despite this, it recorded the highest number of deaths related to COVID-19 (211,155), with a lethality rate of 0.87%, second only to Sweden with 0.88%, where the average adherence to diagnosis was 1.7% of the population. Significant are the data for Israel, where as deaths increased, so did testing (r = 0.62, p < 0.001). Conclusions: To control future outbreaks it’s fundamental satisfying the need for effective testing strategies and government communication, equitable healthcare access, and education in public health and hygiene principles. (www.actabiomedica.it).

Type: Article
Title: Innovative Covid-19 diagnostics and testing strategies in Italy, Denmark, UK, Israel and Sweden: a comparative analysis including tests, incidence and mortality
Location: Italy
Open access status: An open access version is available from UCL Discovery
DOI: 10.23750/abm.v94iS3.14565
Publisher version: https://doi.org/10.23750/abm.v94iS3.14565
Language: English
Additional information: This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Humans, COVID-19, Incidence, Israel, Sweden, SARS-CoV-2, Italy, United Kingdom, Denmark, COVID-19 Testing
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health > Behavioural Science and Health
URI: https://discovery.ucl.ac.uk/id/eprint/10181560
Downloads since deposit
3Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item